SCHEMBL549697

SCHEMBL549697

Oc1ccc(C23CC4CC(CC(C4)C2)C3)c(O)c1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
GFER P55789 1/20 0.49
RARB P10826 5/20 0.41
RARA P10276 5/20 0.41
RARG P13631 4/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
TP53 P04637 2/20 0.40
CYP3A4 P08684 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548533 0.87 MEN1 (0.50) MEN1KMT2APOLBGAAGFER
SCHEMBL4677956 0.86 MEN1 (0.53) MEN1KMT2APOLBGAAGFER
SCHEMBL549937 0.85 MEN1 (0.49) MEN1KMT2APOLBGAAGFER
SCHEMBL3768061 0.85 MEN1 (0.52) MEN1KMT2APOLBGAAGFER
SCHEMBL548996 0.84 MEN1 (0.48) MEN1KMT2APOLBGAAGFER
SCHEMBL548653 0.84 MEN1 (0.59) MEN1KMT2APOLBGAAGFER
SCHEMBL548724 0.82 MEN1 (0.46) MEN1KMT2APOLBGAAGFER
SCHEMBL548545 0.82 NPC1 (0.41) MEN1KMT2APOLBGAAGFER
SCHEMBL548737 0.80 MEN1 (0.46) MEN1KMT2APOLBGAAGFER
SCHEMBL14040622 0.80 MEN1 (0.47) MEN1KMT2APOLBGAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110614-B2 Adamantane derivative, method for producing the same, and resin composition containing adamantane derivative IDEMITSU KOSAN CO., LTD. (JP) 2012-02-07 US disclosed
US-20100056663-A1 ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2010-03-04 US disclosed
CN-101547885-A Adamantane derivative, process for producing the same, and resin composition containing adamantane derivative IDEMITSU KOSAN CO (JP) 2009-09-30 CN disclosed
EP-2090563-A1 ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2009-08-19 EP disclosed
EP-1274755-B1 LOW DIELECTRIC CONSTANT ORGANIC DIELECTRICS BASED ON CAGE-LIKE STRUCTURES HONEYWELL INT INC (US) 2008-02-20 EP disclosed
US-7307137-B2 CROSSLINKING SHELL-CORE POLYMER HONEYWELL INTERNATIONAL INC. (US) 2007-12-11 US disclosed
EP-1373358-A4 LOW DIELECTRIC CONSTANT MATERIALS AND METHODS OF PREPARATION THEREOF HONEYWELL INT INC (US) 2005-03-16 EP disclosed
US-6849696-B2 Low dielectric constant organic dielectrics based on cage-like structures HONEYWELL INTERNATIONAL INC. (US) 2005-02-01 US disclosed
US-20040247896-A1 Organic compositions HONEYWELL INTERNATIONAL INC. 2004-12-09 US disclosed
EP-1461370-A1 ORGANIC COMPOSITIONS Honeywell International Inc. (US) 2004-09-29 EP disclosed
EP-1373358-A1 LOW DIELECTRIC CONSTANT MATERIALS AND METHODS OF PREPARATION THEREOF Honeywell International, Inc. (US) 2004-01-02 EP disclosed
US-20030187139-A1 Low dielectric constant organic dielectrics based on cage-like structures LAU KREISLER (US) 2003-10-02 US disclosed
WO-2003057749-A1 ORGANIC COMPOSITIONS HONEYWELL INTERNATIONAL INC. (US) 2003-07-17 WO disclosed
WO-2003007337-A2 LOW DIELECTRIC CONSTANT ORGANIC DIELECTRICS BASED ON CAGE-LIKE STRUCTURES HONEYWELL INTERNATIONAL INC. (US) 2003-01-23 WO disclosed
US-6509415-B1 Crosslinked polyphenylene ethers with cage compounds attached; integrated circuits HONEYWELL INTERNATIONAL INC. 2003-01-21 US disclosed
EP-1274755-A2 LOW DIELECTRIC CONSTANT ORGANIC DIELECTRICS BASED ON CAGE-LIKE STRUCTURES Honeywell International Inc. (US) 2003-01-15 EP disclosed
WO-2002081546-A1 LOW DIELECTRIC CONSTANT MATERIALS AND METHODS OF PREPARATION THEREOF HONEYWELL INTERNATIONAL INC. (US) 2002-10-17 WO disclosed
US-20020016414-A1 Low dielectric constant organic dielectrics based on cage-like structures HONEYWELL INTERNATIONAL INC. 2002-02-07 US disclosed
WO-2001078110-A2 LOW DIELECTRIC CONSTANT ORGANIC DIELECTRICS BASED ON CAGE-LIKE STRUCTURES HONEYWELL INTERNATIONAL INC. (US) 2001-10-18 WO disclosed
CN-1117966-A Biphenyl derivatives EISAI CO LTD (JP) 1996-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056663-A1 ADAMANTANE DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION CONTAINING ADAMANTANE DERIVATIVE ARCN1, RTN3, CHRNA3 MEN1 3412/4885KMT2A 3737/4885POLB 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.